A pilling-resistant cosmetic composition is in the form of an oil in water emulsion that includes a water phase and an oily phase, and includes at least one cosmetically acceptable polymeric thickener selected from the group consisting of crosspolymers, gums, taurate based polymers, carbomers, polyacrylates, and combinations thereof, at least one ethoxylated agent in liquid form at ambient temperature in a range from about 20° C. to about 28° C. and has an HLB from about 8.5 to about 16; and at least one oil. The pilling-resistant cosmetic composition resists pilling when applied by rubbing or smoothing on a keratinous substrate.

A method of applying a skin peel formulation or product that includes providing a skin peel formulation or product containing at least 10% of the total weight of the skin peel formulation or product being vitamin A. Also provided is vitamin C present in at least 20% of the total weight of the skin peel formulation or product, wherein the vitamin C is in oil soluble form. The skin peel formulation is applied to a region of the body without any acid pre-treatments. After application of the skin peel formulation the user waits at least 25 days before reapplying the skin peel formulation again.

The color composition formula and method of the present invention uses a color composition to create colorful environments of single or multi-colored hues. It is possible to make the color composition into various different shapes and forms, and they have several different uses as well.

A composition comprising at least one dispersed fatty phase, and at least one continuous aqueous phase, and comprising: a) at least one hydrophobic gelling agent selected from ester of dextrin and fatty acid; b) at least one amphiphilic crosslinked copolymer; c) at least one anionic terpolymer, linear or branched, of at least one monomer (1) carrying an acid function in free form, partially or totally salified by a nonionic monomer (2) selected from N,N-dimethylacrylamide and 2-hydroxyethyl acrylate, and at least one monomer (3) polyoxethylenated alkyl acrylate of formula (III) wherein in formula (III): R1 represents a hydrogen atom, R represents a linear or branched C.sub.8-C.sub.16 alkyl radical, n is an integer ranging from 1 to 10; and d) at least one hydrophobic particles chosen from hydrophobic silicas, hydrophobic cellulose, starch, talc, silicone resin powders, hollow hemispherical silicone particles, polyamide powders, hydrophobic pigments, or a mixture thereof. ##STR00001##

A method of moisturizing skin of a person is disclosed. The method can include topically applying to the skin of the person a composition comprising an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract from Parkia biglobosa, wherein the composition moisturizes the skin.

The present invention relates to a skin administration system capable of improving the efficiency of skin delivery of an ingredient for controlling release of neurotransmitters and, particularly, to a microneedle containing an ingredient for controlling release of neurotransmitters.

The present invention relates to a skin administration system capable of improving the efficiency of skin delivery of an ingredient for controlling release of neurotransmitters and, particularly, to a microneedle containing an ingredient for controlling release of neurotransmitters.

Disclosed herein are methods that include contacting a skin surface with a first liquid composition; and then contacting in the skin surface with a cationic coated article loaded with a second liquid composition, while at least some portion of the first liquid composition remains on the skin surface, wherein one or both of the first liquid composition or the second liquid composition includes acrylate copolymer particles dispersed therein, the acrylate copolymer particles including the reaction product of a reaction mixture, the reaction mixture including monomers, the monomers including from about 5 wt % to about 50 wt % of at least one high Tg monomer where the wt % of the high Tg monomer is with respect to the total weight of the monomers in the reaction mixture; and from about 20 wt % to about 80 wt % of at least one low Tg monomer where the wt % of the low Tg monomer is with respect to the total weight of the monomers in the reaction mixture, wherein the particles have a number average diameter of at least about 100 nm and wherein at least one and only one of the first or the second composition comprises greater than or equal to 60 wt % of at least one alcohol.

Disclosed herein are methods that include contacting a skin surface with a first liquid composition; and then contacting in the skin surface with a cationic coated article loaded with a second liquid composition, while at least some portion of the first liquid composition remains on the skin surface, wherein one or both of the first liquid composition or the second liquid composition includes acrylate copolymer particles dispersed therein, the acrylate copolymer particles including the reaction product of a reaction mixture, the reaction mixture including monomers, the monomers including from about 5 wt % to about 50 wt % of at least one high Tg monomer where the wt % of the high Tg monomer is with respect to the total weight of the monomers in the reaction mixture; and from about 20 wt % to about 80 wt % of at least one low Tg monomer where the wt % of the low Tg monomer is with respect to the total weight of the monomers in the reaction mixture, wherein the particles have a number average diameter of at least about 100 nm and wherein at least one and only one of the first or the second composition comprises greater than or equal to 60 wt % of at least one alcohol.

A method of treating skin is disclosed. The method can include topically applying to a peron's skin a composition comprising 0.0001% to 5% w/w of a hydrolyzed algae extract comprising exopolysaccharides from Halymenia durvillei, and 0.0001% to 5% w/w of a saccharide isomerate comprising an exopolysaccharide synthesized by Vibrio alginolyticus, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited in the skin.